This reminds me why today’s $SPX weakness wasn’t about a Gilead drug or whatever. I think many who saw their portfolios shrink into late March are assessing how things look &amp; seeing opportunities to offload some risk assets with the rally testing overhang/overhead resistance. https://t.co/m8JWokBgXm